Capvaxive Vaccine Approval

By Crystal Lubbe

February 6, 2025

What if a single vaccine could significantly change the landscape of pneumococcal disease prevention in adults? The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approving Merck's Capvaxive vacci...
Cost-Effectiveness of Digital HIV Self-Testing
Cervical Cancer Prevention Strategies: Insights from South African
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Transforming Africa through Healthcare Biotechnology Innovation
Cholera Vaccination Campaign Amid Ongoing Outbreak
Blueprint for Transforming Healthcare Access in Africa
Virus-Free Regenerative Medicine: Abu Dhabi’s Stem Cells Center
Advancing Newborn Screening for Sickle Cell Disease in Africa
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives
Maturity Level 3 in Medicines Regulation in Senegal and Rwanda
Infection Control and Disease Surveillance in Africa